Adrian N. Hobden

Adrian N. Hobden

Chief Executive Officer chez Cerespir, Inc.

71 ans
Health Technology
Finance
Consumer Services

Profil

Dr. Adrian N.
Hobden
is a Scientific Advisor at Frantz Medical Ventures and he is the President, Chief Executive Officer & Director at Myrexis, Inc. He is on the Board of Directors at Myrexis, Inc. Dr. Hobden was previously employed as President by Myriad Genetics, Inc. He also served on the board at Glaxo Wellcome, Inc. Dr. Hobden received his undergraduate degree from the University of Cambridge, a graduate degree from the University of Cambridge, and a doctorate degree from the University of Leicester.

Postes actifs de Adrian N. Hobden

SociétésPosteDébut
Private Equity Investor -
Chief Executive Officer -
Director/Board Member -
Tous les postes actifs de Adrian N. Hobden

Anciens postes connus de Adrian N. Hobden

SociétésPosteFin
MYREXIS, INC. Chief Executive Officer 21/07/2011
Glaxo Wellcome, Inc. Corporate Officer/Principal 01/10/1998
MYRIAD GENETICS, INC. President -
Voir l'expérience en détail de Adrian N. Hobden

Formation de Adrian N. Hobden

University of Cambridge Graduate Degree
University of Leicester Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Adrian N. Hobden

Relations

57

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
MYRIAD GENETICS, INC.

Health Technology

MYREXIS, INC.

Finance

Entreprise privées4

Finance

Commercial Services

Glaxo Wellcome, Inc.

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Adrian N. Hobden